Content uploaded by Grant R MacGregor
Author content
All content in this area was uploaded by Grant R MacGregor
Content may be subject to copyright.
A Mouse Model of Mitochondrial Disease Reveals Germline
Selection Against Severe mtDNA Mutations
Weiwei Fan
1,2
, Katrina G. Waymire
1,2
, Navneet Narula
3
, Peng Li
4
, Christophe Rocher
1,2
,
Pinar E. Coskun
1,2
, Mani A. Vannan
4
, Jagat Narula
4
, Grant R. MacGregor
1,5,6
, and
Douglas C. Wallace
1,2,7,*
1
Center for Molecular and Mitochondrial Medicine and Genetics, University of California, Irvine,
CA 92697, USA.
2
Department of Biological Chemistry, University of California, Irvine, CA 92697, USA.
3
Department of Pathology, University of California, Irvine, CA 92697, USA.
4
Division of Cardiology, Department of Medicine, University of California, Irvine, CA 92697, USA.
5
Department of Developmental and Cell Biology, University of California, Irvine, CA 92697, USA.
6
Developmental Biology Center, University of California, Irvine, CA 92697, USA.
7
Departments of Ecology and Evolutionary Biology and Pediatrics, University of California, Irvine,
CA 92697, USA.
Abstract
The majority of mitochondrial DNA (mtDNA) mutations that cause human disease are mild to
moderately deleterious, yet many random mtDNA mutations would be expected to be severe. To
determine the fate of the more severe mtDNA mutations, we introduced mtDNAs containing two
mutations that affect oxidative phosphorylation into the female mouse germ line. The severe ND6
mutation was selectively eliminated during oogenesis within four generations, whereas the milder
COI mutation was retained throughout multiple generations even though the offspring consistently
developed mitochondrial myopathy and cardiomyopathy. Thus, severe mtDNA mutations appear
to be selectively eliminated from the female germ line, thereby minimizing their impact on
population fitness.
The maternally inherited mitochondrial DNA (mtDNA) has a high mutation rate, and
mtDNA base substitution mutations have been implicated in a variety of inherited
degenerative diseases including myopathy, cardiomyopathy, and neurological and endocrine
disorders (1,2). Paradoxically, the frequency of mtDNA diseases is high, estimated at 1 in
5000 (3,4), yet only a few mtDNA mutations account for the majority of familial cases (2).
Because mutations would be expected to occur randomly in the mtDNA, the paucity of the
most severe mtDNA base substitutions in maternal pedigrees suggests that the severe
mutations may be selectively eliminated in the female germ line.
*
To whom correspondence should be addressed. dwallace@uci.edu.
Supporting Online Material
www.sciencemag.org/cgi/content/full/319/5865/958/DC1
Materials and Methods
Figs. S1 to S6
References
NIH Public Access
Author Manuscript
Science. Author manuscript; available in PMC 2011 March 7.
Published in final edited form as:
Science
. 2008 February 15; 319(5865): 958–962. doi:10.1126/science.1147786.
NIH-PA Author Manuscript NIH-PA Author Manuscript NIH-PA Author Manuscript
To investigate this possibility, we have developed a mouse model in which the germline
transmission of mtDNA point mutations of different severity could be tested. An antimycin
A–resistant mouse LA9 cell line was cloned whose mtDNA harbored two homoplasmic
(pure mutant) protein-coding gene base change mutations: one severe and the other mild.
The severe mutation was a C insertion at nucleotide 13,885 (13885insC), which created a
frameshift mutation in the NADH dehydrogenase subunit 6 gene (ND6). This frameshift
mutation altered codon 63 and resulted in termination at codon 79 (Fig. 1A, top; fig. S1A,
bottom). When homoplasmic, this mutation inactivates oxidative phosphorylation complex I
(5). The mild mutation was a missense mutation at nucleotide 6589 (T6589C) in the
cytochrome c oxidase subunit I gene (COI) that converted the highly conserved valine at
codon 421 to alanine (V421A) (fig. S1A, top). When homoplasmic, this mutation reduces
the activity of oxidative phosphorylation complex IV by 50% (6,7).
LA9 cells homoplasmic for both the ND6 frameshift and COI missense mutations were
enucleated, and the mtDNAs were transferred by cytoplast fusion to the mtDNA-deficient
(ρ
o
) mouse cell line LMEB4, generating the LMJL8 transmitochondrial cybrid (8). LMJL8
mitochondria exhibited no detectable oxygen consumption when provided with NADH-
linked complex I substrates (fig. S1B) and no detectable complex I enzyme activity (fig.
S1C). However, the same mitochondria exhibited a 43% increase in succinate-linked
respiration and a 91% increase in complex II + III activity as well as a 62% increase in
complex IV activity (fig. S1, B and C), presumably as a compensatory response to the
severe complex I defect (9). Relative to LM(TK
−
) cells, mouse L cell lines homoplasmic for
the COI missense mutation also showed increased reactive oxygen species (ROS). Cells
homoplasmic for both the ND6 frameshift and COI missense mutations produced fewer
ROS than did the COI mutant cells. However, cells that were 50% heteroplasmic for both
the ND6 frameshift and the COI missense mutations had the highest ROS production (fig.
S1D).
To analyze the fates of the severe ND6 frameshift versus moderate COI missense mtDNA
mutations, we introduced these mutations into the mouse germ line. LMJL8 cybrids were
enucleated and the cytoplasts fused to the mouse female embryonic stem (ES) cell line
CC9.3.1 that had been cured of its resident mitochondria and mtDNAs by treatment with
rhodamine 6G (10–12). Of the 96 resulting ES cybrids, four (EC53, EC77, EC95, and EC96)
were found to be homoplasmic for the COI missense mutation. By quantitative primer
extension–denaturing high-performance liquid chromatography analysis, three of the ES cell
cybrids were also found to be homoplasmic for the ND6 frameshift mutation. However, one
ES cell cybrid, EC77, was heteroplasmic (mixture of mutant and normal mtDNAs); 96% of
the mtDNAs harbored the ND6 frameshift mutation (13885insC), whereas 4% of the
mtDNAs had sustained a secondary deletion of the adjacent T (13885insCdelT), restoring
the reading frame (Fig. 1A, bottom, and Fig. 1B). This ND6 revertant mutation encodes the
normal amino acid sequence but changes leucine codon 60 from TTA to TTG.
EC77 ES cells were injected into female C57BL/6NHsd blastocysts, and the chimeric
embryos were transferred into pseudo-pregnant females (12). Three chimeric females were
generated that contained varying proportions of three mtDNA genotypes: ND6 frameshift +
COI missense, ND6 revertant + COI missense, and wild type (fig. S2). The chimeras were
mated with C57BL/6J (B6) males and produced a total of 111 pups. Only one F
1
agouti
female pup, EC77-AG, was generated harboring the mutant mtDNAs. Analysis of tail
mtDNA by primer extension and by cloning and sequencing revealed that EC77-AG was
homoplasmic for the COI mutant allele but heteroplasmic for the ND6 frameshift (47%) and
ND6 revertant (53%) mtDNAs (fig. S3A). Post mortem analysis at 11 months revealed that
all analyzed tissues from EC77-AG had essentially the same genotype, with an average of
44 ± 3% (range 38% to 50%) of the mtDNAs harboring the ND6 frameshift plus COI
Fan et al. Page 2
Science. Author manuscript; available in PMC 2011 March 7.
NIH-PA Author Manuscript NIH-PA Author Manuscript NIH-PA Author Manuscript
missense mutations (ND6 13885insC + COI T6589C) and 56% harboring the ND6 revertant
plus COI missense mutations (ND6 13885insCdelT + COI T6589C). The highest levels of
the frameshift mutant mtDNA were found in the brain and right oviduct; the lowest level
was found in the left ovary (Fig. 1C).
Throughout the 11 months of her life, EC77-AG displayed no overt phenotype. However,
post mortem mitochondrial enzymatic assays revealed a 10% to 33% decrease of complex I
activity in brain, heart, liver, and skeletal muscle (fig. S3B), a 56% and 46% decrease of
complex IV activity in brain and skeletal muscle, and a 19% and 39% increase of complex
IV activity in heart and liver (fig. S3C). This was associated with structures consistent with
lipid droplets in the heart mitochondria by ultrastructural analysis (compare fig. S3, D and
E).
To analyze transmission of the heteroplasmic, severe, ND6 frameshift (ND6 13885insC +
COI T6589C) mtDNA in successive maternal generations, we mated F
1
female EC77-AG,
which had 47% ND6 frameshift tail mtDNA, with B6 males. EC77-AG gave birth to six
litters totaling 56 pups (N
2
). The proportion of ND6 frameshift tail mtDNA, as assessed by
primer extension analysis, declined to 14% in the first litter of four pups (EC77 #1 to #4)
and the second litter of nine pups (EC77 #5 to #13), then to 6% in the third litter of 10 pups
(EC77 #14 to #23), and finally was lost (0%) in all subsequent litters (Fig. 2A).
To verify the reproducibility of the progressive loss of the ND6 frameshift mtDNA, we
mated N
2
female EC77 #4, which had 14% ND6 frameshift mtDNA, with B6 males. EC77
#4 gave birth to two litters totaling 12 pups (N
3
) (Fig. 2A). Three of the four pups of the first
litter had 6% ND6 frameshift mtDNA, whereas the remaining pup of the first litter and all
eight pups of the second litter had lost the ND6 frameshift mtDNA (0%). We also mated N
2
female EC77 #11, which had 14% ND6 frameshift mtDNA, with B6 males. EC77 #11 gave
birth to two litters totaling 21 pups. One of the 11 pups of the first litter had 6% ND6
frameshift mtDNA, whereas the remaining 10 pups of the first litter and all 10 pups of the
second litter had lost the frameshift mtDNA (0%). Mating of B6 males with N
3
females,
which had 6% ND6 frameshift mtDNA, only produced pups that lacked the ND6 frameshift
mtDNA. These data suggest that the mtDNA harboring the deleterious ND6 frameshift
mutation (13885insC) was selectively and directionally eliminated from the mouse female
germ line within four generations.
To determine whether the ND6 frameshift plus COI missense mtDNA was eliminated from
the female germ line in favor of the ND6 revertant plus COI missense mtDNA via selective
loss of those fetuses with the highest percentages of ND6 frameshift mtDNA, we compared
the litter sizes of females with different proportions of ND6 frameshift mtDNA. Females
with higher percentages of ND6 frameshift mtDNA would be predicted to generate pups
with higher proportions of the ND6 frameshift mtDNA and thus have higher fetal loss rates
and smaller litter sizes. We instead observed that the percentage of ND6 frameshift mtDNA
in the mother had no effect on litter size. The average litter size of F
1
female EC77-AG with
47% ND6 frameshift mtDNA was 9.3 pups per litter, whereas that of two of her daughters
with 14% ND6 frameshift mtDNA was 8.25 pups per litter, and that of her descendants with
6% ND6 frameshift mtDNAs was 8.75 pups per litter. Given that average litter size usually
decreases slightly when backcrossing onto a B6 strain background, the average litter size
appeared unaffected by the proportion of the mother’s mtDNA that harbored the ND6
frameshift mutation, thus arguing against preferential fetal loss as the segregation
mechanism.
To determine whether the ND6 frameshift mtDNA was lost before fertilization or ovulation,
we collected and genotyped individual oocytes from superovulated N
2
females containing
Fan et al. Page 3
Science. Author manuscript; available in PMC 2011 March 7.
NIH-PA Author Manuscript NIH-PA Author Manuscript NIH-PA Author Manuscript
14% ND6 frameshift plus COI missense and 86% ND6 revertant plus COI missense
mtDNA. Of the 12 oocytes that were successfully genotyped, four retained 10 to 16% of the
ND6 frameshift mtDNA, two retained 6% of the ND6 frameshift mtDNA, and five had lost
the frameshift mtDNA (Fig. 2B). Previous studies on mice heteroplasmic for the normal
NZB and Balb/c mtDNAs revealed that these mtDNAs segregated randomly when
transmitted through the female germ line (13). If this was the case for mice that were
heteroplasmic for the ND6 frameshift and ND6 revertant mtDNAs, we would expect that the
percentage of frameshift versus total mtDNAs would be normally distributed around the
mother’s genotype. In fact, none of the oocytes or progeny had a higher proportion of the
ND6 frameshift mutant mtDNA than the mother. This indicates that proto-oocytes with the
higher proportion of frameshift mutant mtDNA must have been eliminated by selection
before ovulation.
As seen with the F
1
female EC77-AG, the proportion of ND6 frameshift mtDNA in the
different tissues of three N
2
mice containing 14% ND6 frameshift and 86% ND6 revertant
mtDNA, all with the COI missense mutation, was relatively constant, ranging between 14%
and 16% (fig. S4A). Ultrastructural analysis of hearts taken from the 14% ND6 frameshift
plus 100% COI missense mice revealed mitochondrial proliferation, evidence of
mitochondrial autophagy, and myofibrillar degeneration (fig. S4, B to D). Biochemical
analysis of brain, heart, and liver of mice with 14% ND6 frameshift plus 100% COI
missense mutant mtDNAs revealed little reduction in complex I activity (fig. S4E);
however, complex IV activity in these tissues was reduced by 28%, 70%, and 59%,
respectively (fig. S4F).
Comparison of the complex I activity in mice harboring 0%, 6%, and 14% ND6 frameshift
and 100% COI missense mtDNAs confirmed that complex I was little affected, with the
possible exception of a modest reduction of complex I in muscle in animals with 14% ND6
frameshift mtDNAs (fig. S5A). The complex II + III activities were also relatively stable
(fig. S5B). However, complex IV was reduced about 50% in brain, liver, heart, and muscle
of the 14%, 6%, and 0% ND6 frameshift plus 100% COI missense mutant mice (Fig. 3A).
Hence, the predominant biochemical defect in animals with 14% or less ND6 frameshift
mtDNAs can be attributed to the homoplasmic COI missense mutation.
Mice that were homoplasmic for the COI missense mutation, linked to the ND6 revertant
mutation (13885insCdelT), transmitted this mtDNA to all of their offspring through multiple
backcrosses to B6 males. Although the phenotype of these mice was grossly normal, muscle
histology of 12-month-old animals revealed ragged red muscle fibers and abnormal
mitochondria characteristic of mitochondrial myopathy (Fig. 3, B to E).
In addition to the mitochondrial myopathy, echocardiographic analysis of 12-month-old COI
missense mice revealed that 100% of these animals (n = 7) had developed a striking
cardiomyopathy, as compared to age-matched B6 control mice (n = 5) (Fig. 4, A and B).
This cardiomyopathy was associated with a 35% increase in left ventricular wall thickness, a
23% reduction in left ventricular inner dimension at end-diastole (P < 0.001), and a 27%
increase in rotation in association with a 28% reduction in circumferential strain vectors (P
< 0.001) and a 42% reduction in radial stretch vectors (P < 0.001) (fig. S6, A and B).
Histology of the COI missense mutant hearts revealed the presence of myocyte hypertrophy,
myofibrillar lysis, binucleate cells, and interstitial fibrosis (Fig. 4, C and D). Focal
inflammation, interstitial edema, and increased blood vessel number and diameter were also
observed (fig. S6, C to E).However, no evidence of the myofiber disarray characteristic of
hypertrophic cardiomyopathy was seen. Cardiac ultrastructural analysis revealed loss of
myofilaments and mitochondrial abnormalities in mutant heart tissue, including
mitochondrial proliferation, reduction in mitochondrial matrix density, and cristolysis (Fig.
Fan et al. Page 4
Science. Author manuscript; available in PMC 2011 March 7.
NIH-PA Author Manuscript NIH-PA Author Manuscript NIH-PA Author Manuscript
4F), relative to age-matched controls (Fig. 4E). Hence, the milder mtDNA COI missense
mutation was successfully transmitted through repeated maternal generations, even though it
caused maternally inherited mitochondrial myopathy and cardiomyopathy.
Our studies suggest that the female germ line has the capacity for intraovarian selection
against highly deleterious mtDNA mutations such as the ND6 frameshift mutation, while
permitting transmission of more moderate mtDNA mutations such as the COI missense
mutation. This observation may explain why there is a dearth of severe mtDNA base
substitution pedigrees in humans, yet more moderate pathogenic mtDNA mutations are
repeatedly seen, such as those causing neurogenic muscle weakness, ataxia, and retinitis
pigmentosa (NARP) T8993G (ATP6 L156R) and Leber hereditary optic neuropathy
(LHON) G11778A (ND4 R340H) and T14484C (ND6 M64V) (2).
Although the mechanism by which the severe mtDNA mutations are recognized and
eliminated remains unclear, our observation that cells heteroplasmic for both the ND6
frameshift and the COI missense mutations have the highest ROS production provides one
possible explanation. It has been proposed that the primordial female germ cells have a
limited number of mtDNAs permitting rapid genetic drift toward pure mutant or wild-type
mtDNA during the approximately 20 female germline cell divisions (13). At birth, the
ovigerous cords reorganize to form single oogonia surrounded by granulosa cells. This
would lead to oogonia within fetal ovigerous cords with mtDNA genotypes symmetrically
distributed around the maternal mean percent heteroplasmy. Of these oogonia, only about
30% complete meiotic maturation; the remainder undergo apoptosis (14,15). Because
apoptosis in preovulatory follicles is thought to be induced by oxidative stress (16), it is
conceivable that the proto-oocytes with the highest percentage of severe mtDNA mutations
produce the most ROS and thus are preferentially eliminated by apoptosis. Such a process
would then lead to the progressive loss of the more deleterious mtDNA mutations over
successive female generations.
Among the pathogenic missense mutations that are observed, the more severe mtDNA
mutations such as NARP T8993G remain heteroplasmic through successive generations. By
contrast, the milder mtDNA mutations, such as LHON G11778A and T14484C, can
segregate to homoplasmic mutant (2). Because heteroplasmy would temper the biochemical
defect associated with the more severe mutations, this observation supports the concept that
the more severe mtDNA defects are eliminated within the maternal germ line.
The existence of a female germline filter for severely deleterious mtDNA mutations makes
evolutionary sense. Assuming that mtDNA variation is pivotal to species adaptation to
changing environments and that the uniparental mtDNA cannot generate diversity by
recombination, then mtDNA diversity must be generated through a high mutation rate (17–
19). However, a high mutation rate would generate many highly deleterious mutations that
could create an excessive genetic load and endanger species fitness. This dilemma can be
resolved by the addition of a graded filter in the female germ line that eliminates the most
severe mutations before conception. For such a filter to succeed, multiple cell divisions
resulting in a large population of proto-oocytes would be required to segregate out the new
mtDNA mutations. This may explain why the mammalian female generates millions of
primordial oogonia but ovulates only a few hundred mature oocytes.
References and Notes
1. Wallace DC. Annu. Rev. Genet 2005;39:359. [PubMed: 16285865]
2. Wallace, DC.; Lott, MT.; Procaccio, V. Emery and Rimoin’s Principles and Practice of Medical
Genetics. ed. 5. Rimoin, DL.; Connor, JM.; Pyeritz, RE.; Korf, BR., editors. Vol. vol. 1.
Philadelphia: Churchill Livingstone; 2007. p. 194-298.
Fan et al. Page 5
Science. Author manuscript; available in PMC 2011 March 7.
NIH-PA Author Manuscript NIH-PA Author Manuscript NIH-PA Author Manuscript
3. Schaefer AM, Taylor RW, Turnbull DM, Chinnery PF. Biochim. Biophys. Acta 2004;1659:115.
[PubMed: 15576042]
4. Schaefer AM, et al. Ann. Neurol. 2007 10.1002/ana.21217.
5. Bai Y, Attardi G. EMBO J 1998;17:4848. [PubMed: 9707444]
6. Acin-Perez R, et al. Hum. Mol. Genet 2003;12:329. [PubMed: 12554686]
7. Kasahara A, et al. Hum. Mol. Genet 2006;15:871. [PubMed: 16449238]
8. Trounce I, Wallace DC. Somat. Cell Mol. Genet 1996;22:81. [PubMed: 8643997]
9. Kokoszka JE, et al. Nature 2004;427:461. [PubMed: 14749836]
10. Levy SE, Waymire KG, Kim YL, MacGregor GR, Wallace DC. Transgen. Res 1999;8:137.
11. Sligh JE, et al. Proc. Natl. Acad. Sci. U.S.A 2000;97:14461. [PubMed: 11106380]
12. MacGregor, GR.; Fan, WW.; Waymire, KG.; Wallace, DC. Embryonic Stem Cells. Notarianni, E.;
Evans, MJ., editors. New York: Oxford Univ. Press; 2006. p. 72-104.
13. Jenuth JP, Peterson AC, Fu K, Shoubridge EA. Nat. Genet 1996;14:146. [PubMed: 8841183]
14. Hussein MR. Hum. Reprod. Update 2005;11:162. [PubMed: 15705959]
15. Tilly JL, Tilly KI. Endocrinology 1995;136:242. [PubMed: 7828537]
16. Tsai-Turton M, Luderer U. Endocrinology 2006;147:1224. [PubMed: 16339198]
17. Wallace DC. Annu. Rev. Biochem 2007;76:781. [PubMed: 17506638]
18. Ruiz-Pesini E, Mishmar D, Brandon M, Procaccio V, Wallace DC. Science 2004;303:223.
[PubMed: 14716012]
19. Ruiz-Pesini E, Wallace DC. Hum. Mutat 2006;27:1072. [PubMed: 16947981]
20. Supported by California Regenerative Medicine Predoctoral Fellowship TI-00008 (W.F.), NIH
grant HD45913 (G.R.M.), and NIH grants NS21328, AG13154, AG24373, DK73691, and
AG16573 (D.C.W.).
Fan et al. Page 6
Science. Author manuscript; available in PMC 2011 March 7.
NIH-PA Author Manuscript NIH-PA Author Manuscript NIH-PA Author Manuscript
Fig. 1.
Qualitative and quantitative analysis of the ND6 frameshift (13885insC) and ND6 revertant
(13885insCdelT) mutations in mouse ES cell cybrids and tissues of F
1
female EC77-AG.
(A) Sequence around nucleotide 13,885 of two clones of mtDNA from EC77 cells. Top
(13885insC), the single C insertion causing the frameshift (asterisk); bottom
(13885insCdelT), the T (arrow) deletion that restored the normal reading frame. (B)
Percentages of ND6 frameshift (13885insC, blue) versus revertant (13885insCdelT, purple)
in four independent mouse ES cybrids. (C) Proportions of ND6 frameshift (13885insC) and
revertant (13885insCdelT) mtDNAs in the tissues of F
1
female EC77-AG.
Fan et al. Page 7
Science. Author manuscript; available in PMC 2011 March 7.
NIH-PA Author Manuscript NIH-PA Author Manuscript NIH-PA Author Manuscript
Fig. 2.
Selective elimination of ND6 frameshift mtDNA (13885insC) from F
1
female EC77-AG and
her offspring. (A) Percentages of ND6 frameshift (13885insC) mtDNAs in EC77-AG and
her offspring, plus the pups of her daughters EC77 #4 and #11. Each offspring was analyzed
from multiple litters. Litter sizes are indicated in parentheses. (B) Percentages of the ND6
frameshift (13885insC, black) and revertant (13885insCdelT, gray) mtDNAs in 12 oocytes
isolated from EC77 progeny mice containing 14% of the ND6 frameshift mutation
(13885insC).
Fan et al. Page 8
Science. Author manuscript; available in PMC 2011 March 7.
NIH-PA Author Manuscript NIH-PA Author Manuscript NIH-PA Author Manuscript
Fig. 3.
Decreased mitochondrial complex IV activity and mitochondrial myopathy in COI mutant
mice. (A) Complex IV activity was reduced to similar extents in various tissues of mutant
mice harboring 0%, 6%, or 14% ND6 frameshift mutations plus 100% COI missense.
Numbers of animals tested: six B6, seven 0% (0% ND6 frameshift plus 100% COI
missense), three 6% (6% ND6 frameshift plus 100% COI missense), and four 14% (14%
ND6 frameshift plus 100% COI missense), with three repeats performed for each test on
each animal. (B and C) Gomori trichrome staining shows increased ragged red fibers
(arrowheads) in skeletal muscle of 12-month-old COI mutant mice (C) compared to age-
matched control (B). (D and E) Electron microscopy (EM) shows altered mitochondrial
morphology (arrowheads) in skeletal muscle of 12-month-old COI mutant (E) mice
compared to age-matched control (D). Scale bars, 75 µm [(B) and (C)], 1 µm [(D) and (E)].
Fan et al. Page 9
Science. Author manuscript; available in PMC 2011 March 7.
NIH-PA Author Manuscript NIH-PA Author Manuscript NIH-PA Author Manuscript
Fig. 4.
Mitochondrial cardiomyopathy in 12-month-old mice homoplasmic for COI missense
mutation. (A) Echocardiographic analysis of control heart. (B) Echocardiographic analysis
of mutant heart showing increased left ventricular wall thickness (LVWT) and decreased left
ventricular internal dimension in diastole (LVIDd). (C) Hematoxylin and eosin–stained
mutant heart showing myofibrolysis (black arrows), myocyte hypertrophy (long white
arrow), and binucleate cells (inset, white arrows). (D) Masson trichrome–stained mutant
heart showing interstitial replacement fibrosis (yellow arrows). (E) EM of mitochondria
(arrowheads) in normal heart. (F) EM of mutant heart showing mitochondrial proliferation,
Fan et al. Page 10
Science. Author manuscript; available in PMC 2011 March 7.
NIH-PA Author Manuscript NIH-PA Author Manuscript NIH-PA Author Manuscript
reduced matrix density, and cristolysis (arrowheads). Scale bars, 500 µm (C), 100 µm (D), 1
µm [(E) and (F)].
Fan et al. Page 11
Science. Author manuscript; available in PMC 2011 March 7.
NIH-PA Author Manuscript NIH-PA Author Manuscript NIH-PA Author Manuscript